Pharma News

17 June 2024

Alembic Pharmaceuticals announces USFDA approval for Icatibant Injection

Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application for Icatibant Injection

17 June 2024

New and crucial role discovered for a protein in the body's immunity against cancer

Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein traditionally known to prevent damage to the body's cells and tissues, plays a critical role in the immune system's defence against cancer. The findings of the study could improve the effectiveness of current cancer immunotherapies.

14 June 2024

Torrent Pharma enters into Non-Exclusive Patent Licensing agreement with Takeda Pharma to Commercialize its Novel Gastrointestinal Drug in India

Torrent Pharmaceuticals Limited announced that it has entered into a non-exclusive patent licensing agreement with Takeda to commercialize Vonoprazan in India. Vonoprozan is a novel potassium-competitive acid blocker (P-CAB), used for the treatment of acid related disorders - Gastroesophageal Reflux Disease (GERD). Torrent will market Vonoprazan under its own trademark, Kabvie.

14 June 2024

Suven to acquire a majority stake in an oligonucleotide focused CDMO player, Sapala Organics

Suven Pharmaceuticals Limited has executed definitive agreements today, i.e. on June 13, 2024, for acquiring 100% of equity shares (on a fully diluted basis) (Proposed Transaction) in Sapala Organics Private Limited.

13 June 2024

Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP,

Glenmark has received final approval by the United States Food and Drug Administration USFDA for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), determined by the FDA to be bioequivalent1 to Nexium.

12 June 2024

Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later

New findings on long COVID long-term effects on health experienced by many who have had COVID-19 present a good-news, bad-news situation, according to a study at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system.

12 June 2024

Researchers take step toward development of universal COVID-19 antibodies

SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical Research Institute (Texas Biomed), the University of Alabama at Birmingham (UAB) and Columbia University have developed a promising new human monoclonal antibody that appears a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2.

12 June 2024

Antioxidant gel preserves islet function after pancreas removal

Before surgeons remove the pancreas from patients with severe, painful chronic pancreatitis, they first harvest insulin-producing tissue clusters, called islets, and transplant them into the vasculature of the liver. The goal of the transplant is to preserve a patient’s ability to control their own blood-glucose levels without insulin injections.

7 June 2024

Google wants to index your DNA

A new DNA search tool, akin to a Google for genetic material, shows great potential, as reported by its Swiss creators. In a groundbreaking study, they managed to index 10 percent of the globes known DNA, RNA, and protein sequences, suggesting that this approach could feasibly expand to encompass the entirety of biological sequence data.